Results 41 to 50 of about 38,072 (215)

Quizartinib in Combination With FLAG‐IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG‐QUIDA): A PETHEMA Phase I‐II Trial

open access: yesAmerican Journal of Hematology, Volume 101, Issue 9, Page 2258-2268, September 2026.
ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal   +29 more
wiley   +1 more source

LE INFEZIONI IN ONCOLOGIA GINECOLOGICA

open access: yes, 2000
TERAPIE PALLATIEVE IN ONCOLOGIA ...
MIGLIERINA M.   +5 more
core   +1 more source

3D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patients

open access: yesHemaSphere, Volume 10, Issue 9, September 2026.
Abstract Relapsed/refractory (R/R) B‐cell lymphomas (B‐NHL) remain incurable, with limited predictive biomarkers to guide immunotherapy. Preclinical platforms that faithfully preserve the immune context and the viability of patient samples are critically needed for relevant high‐throughput drug testing.
Fabien Gava   +20 more
wiley   +1 more source

Osteossarcoma em cão Border Collier

open access: yesPubvet, 2020
Osteossarcoma é uma neoplasia maligna que acomete frequentemente os ossos de cães principalmente os idosos, possuindo alta taxa de metástase sendo seu crescimento bastante alto.
Laide Danielle Coelho da Silva Chaves   +6 more
doaj   +1 more source

Breast Skin Lesions in a 79‐Year‐Old Woman

open access: yes
JEADV Clinical Practice, EarlyView.
Javier Lorenz‐Dolz   +4 more
wiley   +1 more source

De‐escalating radical surgery for select FIGO Stage I cervical cancer

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1181-1187, September 2026.
Abstract Four recent prospective trials demonstrated that de‐escalation of radical surgery for select patients with apparent low‐risk, FIGO Stage I cervical cancer does not compromise cancer‐related survival but does improve quality of life and provide the opportunity to preserve fertility.
Sara Moufarrij   +5 more
wiley   +1 more source

A enfermagem e os cuidados paliativos em oncologia pediátrica: a percepção da criança e família [PDF]

open access: yes, 2012
TCC (graduação em Enfermagem) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Curso de ...
Pires, Aline Santos
core  

O Perfil Sócio-econômico das pacientes internadas na unidade de oncolologia da Maternidade Carmela Dutra [PDF]

open access: yes, 2004
TCC (graduação) - Universidade Federal de Santa Catarina, Centro Sócio Econômico, Curso de Serviço Social.O presente trabalho tem por objetivo identificar o perfil sócio-econômico das pacientes internadas na Unidade de Oncologia da Maternidade Carmela ...
Santos, Camila Ávila dos
core  

Factores que influyen en la toma de decisiones en oncología. Reflexión bioética acerca de la medicina centrada en el paciente

open access: yesBioethics Update
Antecedentes: Los progresos en oncología han permitido disponer de una gran cantidad de intervenciones novedosas, pero en diversas ocasiones no existe certeza sobre los resultados; al no existir una única decisión, es necesario incorporar en la toma de ...
Marytere Herrera-Martínez   +1 more
doaj   +1 more source

Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma

open access: yes
British Journal of Haematology, EarlyView.
Edvan Q. Crusoé   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy